Endothelin receptor antagonists vs placebo
Change from baseline in BDI mean duration of study 14.3 weeks · pulmonary arterial hypertension
1 finding from 1 review
- Endothelin receptor antagonists for pulmonary arterial hypertension 2021 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 788 participantsLow